The girl was diagnosed with stage 2 of the disease, a status that meant her own immune system was making at least two types ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Type 1 diabetes wears many faces—an elusive autoimmune disease, a metabolic mess, a chronic condition that requires lifelong ...

Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...

A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes ...

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease — a ...

The same chemical reaction that makes a piece of freshly toasted bread delicious also happens in our bodies, with far less ...

Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...

Biomea Fusion's experimental drug showed sustained blood sugar control in patients with type 2 diabetes and may benefit those not responding to GLP-1 therapies like Novo Nordisk's Ozempic, it said on ...

In type I diabetes, the beta cells are destroyed, leaving a person with no insulin. In type II diabetes, the beta cells are present but produce too little insulin. As a result, many people with ...

Type 1 Diabetes is sometimes called juvenile diabetes because it often makes its appearance in childhood or adolescence. While the exact cause is mysterious, we know the disease happens because immune ...

Research suggests that exercising later in the day may help people with type 2 diabetes better manage blood glucose.